249 related articles for article (PubMed ID: 22315972)
1. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity.
Sundqvist A; Ten Dijke P; van Dam H
Breast Cancer Res; 2012 Feb; 14(1):204. PubMed ID: 22315972
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
[TBL] [Abstract][Full Text] [Related]
3. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
Lee YJ; Park JH; Oh SM
Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
Taylor MA; Amin JD; Kirschmann DA; Schiemann WP
Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
7. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
8. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Ras GTPase-activating protein SH3 domain-binding protein 1 in the epithelial-to-mesenchymal transition-induced metastasis of breast cancer cells via the Smad signaling pathway.
Zhang H; Ma Y; Zhang S; Liu H; He H; Li N; Gong Y; Zhao S; Jiang JD; Shao RG
Oncotarget; 2015 Jul; 6(19):17039-53. PubMed ID: 25962958
[TBL] [Abstract][Full Text] [Related]
11. Biology of transforming growth factor-β signaling.
Ikushima H; Miyazono K
Curr Pharm Biotechnol; 2011 Dec; 12(12):2099-107. PubMed ID: 21619537
[TBL] [Abstract][Full Text] [Related]
12. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer.
Pal A; Huang W; Li X; Toy KA; Nikolovska-Coleska Z; Kleer CG
Cancer Res; 2012 Sep; 72(18):4818-28. PubMed ID: 22805309
[TBL] [Abstract][Full Text] [Related]
13. Difference of TGF-β/Smads signaling pathway in epithelial-mesenchymal transition of normal colonic epithelial cells induced by tumor-associated fibroblasts and colon cancer cells.
Wang XL; Huang C
Mol Biol Rep; 2019 Jun; 46(3):2749-2759. PubMed ID: 30835040
[TBL] [Abstract][Full Text] [Related]
14. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
[TBL] [Abstract][Full Text] [Related]
15. Smad phospho-isoforms direct context-dependent TGF-β signaling.
Matsuzaki K
Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta biology in mammary development and breast cancer.
Moses H; Barcellos-Hoff MH
Cold Spring Harb Perspect Biol; 2011 Jan; 3(1):a003277. PubMed ID: 20810549
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.
Dong H; Diao H; Zhao Y; Xu H; Pei S; Gao J; Wang J; Hussain T; Zhao D; Zhou X; Lin D
Cell Prolif; 2019 Sep; 52(5):e12633. PubMed ID: 31264317
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β.
Alcaraz LB; Exposito JY; Chuvin N; Pommier RM; Cluzel C; Martel S; Sentis S; Bartholin L; Lethias C; Valcourt U
J Cell Biol; 2014 May; 205(3):409-28. PubMed ID: 24821840
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
20. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
